###begin article-title 0
###xml 27 32 <span type="species:ncbi:4932">yeast</span>
Domain organization of the yeast histone chaperone FACT: the conserved N-terminal domain of FACT subunit Spt16 mediates recovery from replication stress
###end article-title 0
###begin p 1
###xml 95 116 95 116 <email xmlns:xlink="http://www.w3.org/1999/xlink">Richard.Singer@Dal.ca</email>
To whom correspondence should be addressed. Tel: +1 902 494 8847; Fax: +1 902 494 1355; Email: Richard.Singer@Dal.ca
###end p 1
###begin p 2
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 2
###begin p 3
###xml 167 172 <span type="species:ncbi:4932">yeast</span>
###xml 436 441 <span type="species:ncbi:4932">yeast</span>
The abundant nuclear complex termed FACT affects several DNA transactions in a chromatin context, including transcription, replication, and repair. Earlier studies of yeast FACT, which indicated the apparent dispensability of conserved sequences at the N terminus of the FACT subunit Cdc68/Spt16, prompted genetic and biochemical studies reported here that suggest the domain organization for Spt16 and the other FACT subunit Pob3, the yeast homolog of the metazoan SSRP1 protein. Our findings suggest that each FACT subunit is a multidomain protein, and that FACT integrity depends on Pob3 interactions with the Spt16 Mid domain. The conserved Spt16 N-terminal domain (NTD) is shown to be without essential function during normal growth, but becomes important under conditions of replication stress. Genetic interactions suggest that some functions carried out by the Spt16 NTD may be partially redundant within FACT.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 6 8 6 8 <underline xmlns:xlink="http://www.w3.org/1999/xlink">Fa</underline>
###xml 18 19 18 19 <underline xmlns:xlink="http://www.w3.org/1999/xlink">C</underline>
###xml 28 29 28 29 <underline xmlns:xlink="http://www.w3.org/1999/xlink">T</underline>
###xml 216 240 216 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c1">1</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c5">5</xref>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c6">6</xref>
###xml 209 214 <span type="species:ncbi:4932">yeast</span>
###xml 216 240 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 331 336 <span type="species:ncbi:4932">yeast</span>
FACT (Facilitates Chromatin Transcription) is an abundant complex that functions at the interface between chromatin and several enzymes that affect DNA. FACT has been identified biochemically in metazoans and yeast (Saccharomyces cerevisiae), and the genes encoding FACT subunits are conserved in the eukaryotic lineage (1-4). For yeast-cell viability the subunits of FACT are essential (5,6), almost certainly due to important chromatin-related processes that FACT mediates. These processes include transcription, DNA replication and DNA repair.
###end p 5
###begin p 6
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c7">7</xref>
###xml 156 164 156 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c2">2</xref>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c7">7</xref>
###xml 274 282 274 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c8">8</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c9">9</xref>
###xml 466 474 466 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c2">2</xref>
###xml 544 545 544 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c10">10</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c11">11</xref>
###xml 624 625 624 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 636 644 636 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c11">11</xref>
###xml 816 824 816 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c12">12</xref>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c13">13</xref>
###xml 879 886 879 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 888 890 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c14">14</xref>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c15">15</xref>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c16">16</xref>
###xml 1037 1038 1037 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c17">17</xref>
###xml 1044 1051 1044 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c18">18</xref>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c20">20</xref>
###xml 1287 1289 1287 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c21">21</xref>
###xml 1362 1370 1362 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1415 1417 1415 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c22">22</xref>
###xml 1528 1535 1528 1535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1537 1539 1537 1539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c10">10</xref>
###xml 915 920 <span type="species:ncbi:4932">yeast</span>
FACT (7) was initially identified as an agent that facilitates the passage of the RNA polymerase II (RNAPII) enzyme along a simple nucleosomal DNA template in vitro (2,7). FACT counteracts negative effects of the nucleosomal configuration of DNA on transcription elongation in vitro, most likely through its activities as a histone chaperone involved in the reversible reconfiguration of the nucleosome [reviewed in (8,9)]. FACT binds nucleosomes and H2A*H2B dimers in vitro, an activity correlated with the transcription of nucleosomal DNA (2,4,10,11). FACT also destabilizes interactions between H2A*H2B dimers and (H3*H4)2 tetramers in vitro (11), and may therefore mediate transcription by facilitating H2A*H2B displacement from the nucleosome. Displacement of an H2A*H2B histone dimer facilitates transcription in vitro (12,13), and is also seen upon transcription activity in vivo (14,15). Genetic studies in yeast support a role for FACT in nucleosome reconfiguration (16), and highlight the involvement of FACT in transcription (4,17). In vivo, FACT is distributed along transcribed regions in parallel with RNAPII (18-20) and can be found physically associated with the transcriptionally engaged form of RNAPII, further evidence for a role for FACT in transcription elongation (21). FACT also has chromatin-independent positive effects on transcription in vitro that are exerted at a post-initiation step (22), and FACT interaction with at least one sequence-specific DNA-binding protein is important for transcription in vivo (10).
###end p 6
###begin p 7
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c5">5</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c17">17</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c19">19</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c23">23</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c27">27</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c19">19</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c27">27</xref>
FACT also has a negative role in vivo, mediating the repressive effects of chromatin on transcription (5,17,19,23-27). This activity of FACT is seen in the chromatin repression that normally prevents transcription when activators are absent or ineffective; FACT mutations can disrupt this repression, perhaps by impairing the reestablishment of proper nucleosome organization after the passage of RNAPII (19,27).
###end p 7
###begin p 8
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 99 107 99 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c3">3</xref>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol1</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc17</italic>
###xml 321 322 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c6">6</xref>
###xml 323 325 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c28">28</xref>
###xml 410 411 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c6">6</xref>
###xml 474 476 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c29">29</xref>
###xml 906 907 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 908 910 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c28">28</xref>
###xml 71 78 <span type="species:ncbi:8355">Xenopus</span>
###xml 151 156 <span type="species:ncbi:4932">yeast</span>
###xml 336 341 <span type="species:ncbi:4932">yeast</span>
###xml 870 875 <span type="species:ncbi:4932">yeast</span>
FACT is also involved in DNA replication. Immunodepletion of FACT from Xenopus oocytes compromises in vitro DNA synthesis (3), and mutations affecting yeast FACT show genetic interactions with a pol1/cdc17 mutation affecting DNA polymerase alpha, the catalytic subunit of the lagging-strand DNA polymerase alpha complex (6,28). Indeed, yeast FACT can be affinity-purified using immobilized Pol1/Cdc17 protein (6), and copurified with the 4-subunit polymerase alpha complex (29). Other evidence comes through the use of hydroxyurea (HU), a free-radical scavenger that causes replication stress by inhibiting the enzyme ribonucleotide reductase and limiting the synthesis of deoxyribonucleotides. Sensitivity to HU is conferred by many mutations that affect replication, as well as by mutations that impair the responses to replication stress. Several mutations affecting yeast FACT cause sensitivity to HU (4,28).
###end p 8
###begin p 9
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c30">30</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c31">31</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c32">32</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c34">34</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c35">35</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c36">36</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c37">37</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 428 433 <span type="species:ncbi:4932">Yeast</span>
A DNA-repair role for FACT is also evident. In human cells, DNA damage caused by UV irradiation is potentiated in part through transcription-activation functions of p53 [reviewed in (30,31)]; one facet of this potentiation is the phosphorylation of serine 392 at the C terminus of p53 (32-34). This phosphorylation can be carried out by a complex of FACT and casein kinase II (CK2), with FACT providing p53 specificity (35,36). Yeast FACT also associates with CK2 (37).
###end p 9
###begin p 10
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c38">38</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c39">39</xref>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c40">40</xref>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c41">41</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c40">40</xref>
###xml 154 159 <span type="species:ncbi:4932">yeast</span>
###xml 171 176 <span type="species:ncbi:9606">human</span>
###xml 476 481 <span type="species:ncbi:4932">yeast</span>
###xml 870 875 <span type="species:ncbi:4932">yeast</span>
The subunits of FACT, encoded by single genes in the genomes of eukaryotes examined so far, are highly conserved. The smaller FACT subunit is named Pob3 (yeast) or SSRP1 (human). Pob3 and SSRP1 are closely related sequences, but SSRP1 has an additional domain at its C terminus that is not found in Pob3. This domain, a high mobility group (HMG) fold, can bind damaged and distorted DNA (38,39). Pob3 lacks this HMG domain; however, the small HMG protein Nhp6 associates with yeast FACT and facilitates the binding of FACT to nucleosomes and the resulting nucleosome reorganization (4,40,41). A Pob3-Nhp6 fusion protein that mimics the structure of SSRP1 provides all essential Pob3 functions and many of the functions of Nhp6, including the restoration of chromatin repression (40). Thus Pob3 and Nhp6 may comprise a bipartite version of SSRP1. This difference between yeast and metazoan FACT may reflect additional roles for Nhp6 that do not involve FACT.
###end p 10
###begin p 11
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c5">5</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c17">17</xref>
###xml 330 344 330 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc68-&#916;922</italic>
###xml 346 360 342 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 372 374 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c26">26</xref>
###xml 444 458 436 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 612 614 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c26">26</xref>
###xml 105 110 <span type="species:ncbi:4932">yeast</span>
###xml 238 243 <span type="species:ncbi:4932">yeast</span>
The larger subunit of FACT has been variously termed Cdc68 or Spt16, for its original discoveries in the yeast system (5,17). Despite end-to-end conservation of the Spt16 protein in a wide variety of eukaryotes, the N-terminal 30% of the yeast Spt16 polypeptide can be deleted without loss of essential functions, as shown by the cdc68-Delta922 (spt16-Delta922) mutation (26). However, chromatin repression is compromised by this mutation, and spt16-Delta922 mutant cells are also temperature sensitive for cell proliferation, indicating that essential functions are compromised at elevated growth temperatures (26).
###end p 11
###begin p 12
###xml 174 179 <span type="species:ncbi:4932">yeast</span>
The apparent dispensability of conserved sequences at the N terminus of FACT subunit Spt16 has prompted genetic and biochemical investigations of the domain organization for yeast FACT. Our data suggest that each FACT subunit is a multidomain protein and that the N-terminal domain (NTD) of Spt16 is indeed dispensable during normal growth, in part through redundant function with the rest of FACT. Previously reported temperature-sensitive mutations in the Spt16 NTD were found to destabilize the entire Spt16 polypeptide, accounting for the temperature sensitivity of mutations in this non-essential domain. The Spt16 NTD does become important under conditions of replication stress, where it mediates adaptation to stress conditions.
###end p 12
###begin title 13
MATERIALS AND METHODS
###end title 13
###begin title 14
Strains and plasmids
###end title 14
###begin p 15
###xml 4 15 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 67 69 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c26">26</xref>
###xml 80 97 76 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16&#916;::KanMX</italic>
###xml 107 109 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c42">42</xref>
###xml 125 130 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
###xml 180 181 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c5">5</xref>
###xml 182 184 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c24">24</xref>
###xml 295 299 287 291 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 365 376 357 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 403 417 391 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
The spt16-Delta(6-435) mutation was identified in strain DE4B-17b (26). Haploid spt16Delta::KanMX strains (42) maintained by spt16 plasmids were derived from diploid strains BM64 (5,24) and W303. Plasmid pJW212, a gift from L. Howe and J. L. Workman, encodes full-length Spt16 with a C-terminal flag epitope; p314-M68 that carries a 3.5 kbp BamHI fragment encoding spt16-Delta(6-435). The plasmid-borne spt16-DeltaNTD mutant allele was created from pJW212, after destruction of the SacII polylinker site, by cleavage at the open reading frame (ORF) N-terminal NcoI site in pJW212 and at the downstream BtgI site, followed by blunt-end ligation.
###end p 15
###begin title 16
Partial proteolysis
###end title 16
###begin p 17
###xml 35 37 35 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c40">40</xref>
###xml 78 79 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 141 142 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 191 193 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c40">40</xref>
###xml 356 357 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c1">1</xref>
###xml 389 390 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 410 414 398 402 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 428 430 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c43">43</xref>
###xml 573 574 561 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 594 595 582 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 673 677 661 665 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 807 814 <span type="species:ncbi:3847">soybean</span>
Whole cell extracts were prepared (40) from cells grown to approximately5 x 107 cells/ml in YM1 rich medium, and FACT containing Pob3-(V5+His6) was purified by metal affinity chromatography (40). Size-exclusion chromatography was carried out in 50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 2% glycerol, 1 mM 2-mercaptoethanol, 0.5 mM EDTA as described previously (1). FACT composed of Pob3-(V5+His6), and either Spt16-flag or HA-Spt16 (43) was digested with trypsin, endoprotease Glu-C, or chymotrypsin (all Sigma) at a ratio of 150:1 (w/w) in extraction buffer containing 50 mM NH4 acetate, 50 mM MgCl2 and 100 mM NaCl. For Pob3 analysis, partially purified FACT containing Spt16-flag was digested with trypsin or Glu-C at 25:1 ratio (w/w). Trypsin and chymotrypsin digestions were stopped with a 5-fold excess of soybean trypsin inhibitor (Sigma), while Glu-C digestions were stopped by heat denaturation in SDS loading buffer at 95degreesC for 10 min.
###end p 17
###begin title 18
Purification of FACT to homogeneity
###end title 18
###begin p 19
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c43">43</xref>
###xml 447 448 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 902 906 878 882 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 1023 1027 999 1003 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
A 3 l overnight culture at 7 x 107 cells/ml was diluted with 0.3 vol fresh YM1 medium and incubated for 6 h; cells were then harvested, washed with 0.9% NaCl, resuspended in 150 ml extraction buffer containing 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10% glycerol, 2 mM 2-mercaptoethanol, 4 mM EDTA, 0.1% Tween-20, and protease inhibitor mix (43), and broken using a French pressure cell (15 000 psi). The lysate was clarified by centrifugation (8000 g, 10 min), and the resulting pellet was re-extracted by sonication in 50 ml extraction buffer made to 0.5 M NaCl and centrifuged again. Pooled extract (approximately300 ml) was adjusted to 150 mM NaCl, pH 7.4 and loaded onto a 50 ml DE-52 column, which was washed with 150 ml extraction buffer and eluted with a 120 ml 0.15-0.5 M NaCl gradient at 1.7 ml/min. Fractions containing FACT were pooled (approximately24 ml) and loaded (3x) onto a 0.15 ml anti-flag-agarose (Sigma) column, which was washed with extraction buffer and eluted with 0.3 ml extraction buffer containing flag peptide (0.16 mg/ml; Sigma). The final yield of FACT was approximately60 mug, as determined by Coomassie staining.
###end p 19
###begin title 20
GST-Pob3 fusion proteins
###end title 20
###begin p 21
###xml 43 44 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 376 392 376 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 776 778 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c44">44</xref>
###xml 969 971 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c45">45</xref>
###xml 376 392 <span type="species:ncbi:562">Escherichia coli</span>
Plasmids for the production of glutathione S-transferase (GST)-Pob3 fusion proteins were constructed from PCR-amplified fragments of POB3, using Pfx Taq (Invitrogen) and primers containing BamHI and EcoRI restriction enzyme recognition sequences for directional, in-frame cloning into the expression vector pGEX2T (Pharmacia Biotech). Resulting plasmids were transformed into Escherichia coli cells (strain Top10), which were grown at 37degreesC to an optical density (600) of approximately0.5, at which point expression of GST polypeptides was induced by a 4 h incubation in 37degreesC in a medium containing 1 mM isopropyl-1-thio-beta-D-galactopyranoside (Invitrogen); cells were then pelleted and stored at -20degreesC. Cell extracts were prepared as described previously (44). Glutathione-agarose beads (Sigma) as a 50% slurry in PBS were added and incubated at 4degreesC for 1 h with gentle agitation; bead-bound material was then treated as described previously (45). For quantitation, Coomassie-stained samples, resolved electrophoretically on denaturing 10% polyacrylamide gels, were compared to known quantities of BSA. Amounts of 50% GST-bead slurry were adjusted to make bound proteins equimolar for GST-pulldown assays.
###end p 21
###begin title 22
Recombinant Spt16 polypeptides
###end title 22
###begin p 23
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPT16</italic>
###xml 328 329 328 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 363 369 363 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c44">44</xref>
###xml 363 369 <span type="species:ncbi:562">E.coli</span>
Fragments of the SPT16 gene were PCR-amplified using Pfx Taq (Invitrogen) and primers that contained BamHI and SstI restriction enzyme recognition sequences, for directional cloning into vector pET32-LIC (Novagen). Expression from pET-Spt16 plasmids, encoding Spt16 polypeptide sequences fused N-terminally to thioredoxin, a His6 tag, and an S-tag was induced in E.coli (strain BL21-DE3) as described above. Recombinant proteins were purified under denaturing conditions essentially as described in Novagen's His*Bind Kits Inclusion Body Purification and Resin Chromatography sections. Urea was removed by sequential dialysis against buffer A (44) containing 4 M urea, then 2 M, and finally no urea. Samples were quantified as above, and centrifuged to remove any particulate matter before use.
###end p 23
###begin title 24
GST-pulldown assays
###end title 24
###begin p 25
###xml 753 755 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c43">43</xref>
Equimolar amounts of GST-Pob3 proteins and purified recombinant Spt16 polypeptides were incubated in a 50% glutathione-agarose bead slurry along with BSA (150 mug/ml) in buffer A containing protease inhibitors, or for high-stringency conditions in buffer B (buffer A made to 1% NP-40 and 0.5% sodium deoxycholate, plus protease inhibitors). Mixtures were rocked gently at 23degreesC for 1 h and then beads and supernate were separated. Pelleted beads were next washed for 15 min (five times) at 23degreesC in either PBS with 2% NP-40 and protease inhibitors, or buffer B (for higher stringency), suspended in an equal volume of 2x Laemmli loading buffer and boiled. Half of each solubilized sample and 5% of supernate were assessed by western blotting (43), using S-protein conjugated to HRP (Novagen) to detect recombinant Spt16 polypeptides.
###end p 25
###begin title 26
RESULTS
###end title 26
###begin title 27
Non-essential Spt16 N-terminal sequences
###end title 27
###begin p 28
###xml 4 18 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc68-&#916;922</italic>
###xml 20 34 16 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 53 54 45 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
###xml 262 264 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c26">26</xref>
###xml 304 318 296 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 518 532 506 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
The cdc68-Delta922 (spt16-Delta922) mutation (Figure 1A) is an in-frame internal deletion that eliminates residues 6-306 from the 1035-residue Spt16 protein. Cells with this mutation are temperature-sensitive for growth and compromised for chromatin repression (26). Derivatives of temperature-sensitive spt16-Delta922 cells were selected that had become temperature-resistant due to the acquisition of a suppressor mutation. One suppressor mutation was found, by segregation analysis, to be genetically linked to the spt16-Delta922 locus, and was subjected to further analysis.
###end p 28
###begin p 29
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
###xml 39 53 39 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 195 209 191 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 269 283 261 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 399 400 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
###xml 691 702 671 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 820 834 796 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 845 847 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c26">26</xref>
###xml 950 963 922 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">his4-912&#948;</italic>
###xml 968 981 936 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lys2-128&#948;</italic>
###xml 1100 1101 1064 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1166 1168 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c46">46</xref>
###xml 1169 1171 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c47">47</xref>
###xml 1186 1200 1150 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 1268 1270 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c26">26</xref>
###xml 1277 1288 1237 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 1453 1454 1409 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
###xml 1468 1479 1424 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 1582 1596 1534 1544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 1620 1622 1568 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c26">26</xref>
###xml 1666 1677 1614 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 1742 1756 1686 1696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
Sequencing of the spt16 locus from the spt16-Delta922 isolate containing the linked dominant suppressor mutation showed that the suppressor mutation is an additional in-frame deletion within the spt16-Delta922 ORF, removing 369 nucleotides downstream from the original spt16-Delta922 internal deletion. The resulting polypeptide lacks residues 6-435, with the residues IDPSED in their place (Figure 1A). This truncated Spt16 protein, termed Spt16-Delta(6-435), provides essential functions even at elevated temperatures and thus is more effective that the original Spt16-Delta922 protein, which misses only residues 6-306. Improved function due to the intragenic suppressing deletion in the spt16-Delta(6-435) mutant allele is also seen with respect to chromatin repression of transcription, which is compromised by the spt16-Delta922 mutation (26). Chromatin repression is measured by the degree of functional expression of the 'Spt' reporter genes his4-912delta and lys2-128delta; more expression of these reporter genes confers the ability to grow on media lacking histidine and/or lysine (the Spt- phenotype), and is indicative of impaired chromatin repression (46,47). Whereas the spt16-Delta922 mutant allele allows the growth of cells on these deficient media (26), the spt16-Delta(6-435) allele significantly decreases growth under these conditions, and thus restores a significant degree of chromatin repression at these reporter genes (Figure 1A). Moreover, spt16-Delta(6-435) in the homozygous diploid state also supports sporulation (data not shown), which the original spt16-Delta922 allele does not allow (26). Thus the additional internal deletion in spt16-Delta(6-435) suppresses the deleterious effects of the less extensive spt16-Delta922 internal deletion while maintaining effective essential Spt16 function.
###end p 29
###begin title 30
###xml 4 18 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;369</italic>
###xml 23 34 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
The spt16-Delta369 and spt16-Delta(2-484) mutations suggest an NTD
###end title 30
###begin p 31
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
###xml 136 147 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 202 216 198 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;369</italic>
###xml 265 279 257 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 416 430 404 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 490 491 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
###xml 529 543 513 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;922</italic>
###xml 567 581 547 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;369</italic>
###xml 644 645 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 653 654 629 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 725 738 701 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">his4-912&#948;</italic>
###xml 743 756 715 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lys2-128&#948;</italic>
###xml 780 781 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
###xml 1169 1170 1133 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
Two more spt16 mutant genes harboring large deletions were created and tested for function. Fragment replacement was used to modify the spt16-Delta(6-435) mutant allele, thus creating the mutant allele spt16-Delta369. This gene lacks the deletion characteristic of spt16-Delta922, but retains the in-frame internal deletion (ORF basepairs 936-1304, encoding amino acids 312-435) that suppresses the phenotype of the spt16-Delta922 internal deletion, with all other sequences intact (Figure 1A). Like the original deletion allele spt16-Delta922, the internal deletion spt16-Delta369 causes temperature sensitivity and allows (weak) growth on His- and Lys- media, indicating that chromatin repression of the Spt reporter genes his4-912delta and lys2-128delta is compromised (Figure 1A). Thus, the combined deletion of two adjacent segments of the Spt16 protein, residues 6-306 and 312-435 [resulting in the Spt16-Delta(6-435) protein described above], has only limited effects under the conditions tested, while the presence of either of the N-terminal polypeptide segment in the absence of the other causes problems related to chromatin regulation (summarized in Figure 1A).
###end p 31
###begin p 32
###xml 102 116 102 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 125 126 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
###xml 362 375 354 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">his4-912&#948;</italic>
###xml 380 393 368 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lys2-128&#948;</italic>
###xml 417 418 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
###xml 769 770 745 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 781 783 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c40">40</xref>
###xml 1121 1122 1089 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
###xml 1131 1138 1099 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1478 1480 1438 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c26">26</xref>
###xml 1491 1492 1451 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
###xml 1578 1580 1538 1540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c26">26</xref>
###xml 590 595 <span type="species:ncbi:4932">yeast</span>
A more extensively deleted mutant allele was created using convenient restriction sites. This allele, spt16-DeltaNTD (Figure 1A), lacks codons 2-484 but provides all essential functions of Spt16. Cells in which the Spt16-DeltaNTD polypeptide is the only version of Spt16, grow at high temperature and maintain a significant degree of chromatin repression at the his4-912delta and lys2-128delta reporter genes (Figure 1A). These findings suggested that the Spt16-DeltaNTD protein, and the Spt16-Delta(6-435) protein described above, maintain effective interactions with the other subunit of yeast FACT, Pob3. This conjecture was tested directly by competitive co-immunoprecipitation experiments. Anti-V5 antibody was used to immunoprecipitate epitope-tagged Pob3-(V5+His6) protein (40) from cells harboring two versions of Spt16 protein, full-length Spt16 and either Spt16-Delta(6-435) or Spt16-DeltaNTD. Under these conditions, in which the total amount of Spt16 polypeptide was in excess, the truncated versions of Spt16 co-immunoprecipitated with Pob3, although somewhat less effectively than full-length Spt16 (Figure 1B). This in vivo Pob3 binding by N-terminally truncated Spt16 polypeptides, and their ability to provide essential functions, indicate that sequences downstream from residue 484 fold properly in the absence of upstream sequences, and begin to suggest a domain organization for Spt16. The more extensively deleted Spt16-DeltaCS polypeptide [Cdc68-DeltaCS, (26)] (Figure 1A) lacking N-terminal residues down to position 556 cannot supply essential function (26), consistent with a domain boundary in the 485-555 region.
###end p 32
###begin title 33
Spt16 domains suggested by partial proteolysis of native FACT
###end title 33
###begin p 34
In parallel with the above genetic studies, we assessed domain boundaries using limited proteolysis. Proteases with different cleavage specificities, namely trypsin, chymotrypsin and endoprotease Glu-C (V8 protease), were used to digest purified FACT, and the sizes of the resulting fragments were estimated by denaturing gel electrophoresis. FACT composed of epitope-tagged Spt16 and Pob3 proteins was used, which allowed direct identification of N-terminal and/or C-terminal polypeptides.
###end p 34
###begin p 35
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c40">40</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c43">43</xref>
###xml 202 203 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 229 236 229 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 509 510 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 355 362 <span type="species:ncbi:3847">soybean</span>
FACT containing N-terminally HA-tagged Spt16 supplies all essential functions, as does FACT containing C-terminally (V5+His6)-tagged Pob3 (40,43). A version of FACT composed of HA-Spt16 and Pob3-(V5+His6) is similarly functional in vivo (data not shown). This doubly tagged FACT was digested with trypsin for increasing times, proteolysis was halted with soybean trypsin inhibitor, and the digest was analyzed by western blotting. Anti-HA antibody detected a major 55 kDa N-terminal fragment of Spt16 (Figure 2A, NTD). This disjoined N-terminal fragment, the NTD, was stable to incubation with trypsin after all full-length Spt16 protein had been cleaved, indicating that the trypsin-generated NTD maintains a folded state. Glu-C also generated an HA-tagged Spt16 NTD of similar size (data not shown), consistent with preferential proteolytic cleavage in a boundary region defining the 55 kDa NTD (excluding the HA tag) as an independently folded domain.
###end p 35
###begin p 36
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
The above trypsin digestion of FACT that contained HA-tagged Spt16 also generated smaller HA-tagged polypeptide fragments, suggesting that the NTD may be folded into subdomains (Figure 2A; see also 2D). This possibility is supported by NTD sequence considerations (see Discussion).
###end p 36
###begin p 37
###xml 316 320 316 320 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 336 340 336 340 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 428 429 428 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c1">1</xref>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 877 881 877 881 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 946 947 946 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
Partial proteolysis also produced HA-tagged polypeptides larger than the NTD, highlighting downstream cleavage sites that suggested the presence of a C-terminal domain (CTD). To assess the presence of an independently folded CTD of Spt16, we used purified FACT that contained Spt16 tagged at its C terminus with the flag epitope. Spt16-flag provides all essential functions (data not shown), even when combined with Pob3-(V5+His6) or with Pob3 HA-tagged at its N terminus [(1); data not shown]. Both of these doubly tagged versions of FACT were separately subjected to limited digestion with trypsin, chymotrypsin, or Glu-C. All three enzymes generated a C-terminal Spt16 fragment of 28 kDa (Figure 2B, and data not shown), indicating that the boundary between this Spt16 CTD and the upstream 'middle' domain is highly accessible. Trypsin and Glu-C also produced a major Spt16-flag fragment of 62 kDa, consistent with Spt16 minus its NTD (Figure 2B, Spt16-DeltaNTD); Glu-C, but not the other enzymes, also produced a 46 kDa C-terminal fragment (data not shown). These findings suggest that, as a subunit of FACT, Spt16 is folded into three major domains: a 55 kDa NTD, a 28 kDa CTD, and a 34 kDa middle (Mid) domain, which itself may comprise subdomains.
###end p 37
###begin p 38
The 62 kDa fragment (Spt16 minus its NTD) generated by trypsin cleavage was analyzed by Edman sequencing, which showed that trypsin cleaved at arginine 485. This residue is at the downstream end of a approximately30-residue span that shows limited sequence conservation. This span is devoid of cleavage sites for chymotrypsin, consistent with the absence of a disjoined NTD fragment in chymotrypsin digests (data not shown). The NTD boundary suggested by partial proteolysis is consistent with the activity of the Spt16-DeltaNTD mutant polypeptide created genetically as described above, which comprises the intact Mid and C-terminal domains.
###end p 38
###begin p 39
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 420 421 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 452 453 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
The domain structure of Spt16 suggested above is supported by the trypsin cleavage pattern of FACT purified to homogeneity. The resistance of Pob3 to low levels of trypsin (see below) allowed the identification of silver-stained Spt16 fragments (Figure 2C, lanes 2 and 3). In this analysis the NTD and the combined Mid+CTD (Spt16-DeltaNTD) were especially resistant to proteolysis, while the CTD was more labile (Figure 2C, and data not shown). Figure 2D summarizes Spt16 domain organization.
###end p 39
###begin p 40
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c1">1</xref>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
To assess the folded nature of the disjoined Spt16 NTD, affinity-purified FACT containing HA-Spt16 was treated lightly with trypsin to an extent that generated some Spt16 NTD cleavage product but which also left some FACT undigested (Figure 2A). This mixture was then resolved by exclusion chromatography to size-fractionate the NTD, FACT minus the NTD, and undigested FACT, which runs at >200 kDa [Figure 2E; (1)]. Western analysis of the column eluate showed that, while a portion of the NTD fractionated as a monomer, much of the disjoined NTD co-migrated with intact FACT as indicated by undigested, full-length Spt16 (Figure 2E), most likely as a result of the maintenance of NTD non-covalent interactions after trypsin cleavage.
###end p 40
###begin p 41
###xml 170 174 170 174 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
A different result was obtained by similar analysis, using the same buffer conditions, of the Spt16 CTD. Size-fractionation of trypsin-digested FACT that contained Spt16-flag showed that the bulk of the disjoined CTD fractionated away from Pob3 (Figure 2F), indicating little non-covalent association with other domains of FACT.
###end p 41
###begin p 42
###xml 23 24 23 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f1">1</xref>
###xml 30 31 30 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 602 606 598 602 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 656 663 652 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 699 707 695 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 623 627 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The results in Figures 1B and 2F suggest that the Pob3 interacts with the Spt16 Mid domain. To learn more about this interaction, the blot in Figure 2F was reprobed with polyclonal anti-Spt16 antibody, which detected an untagged Mid domain co-migating with Pob3 (data not shown). Thus the Spt16 CTD is not necessary for Pob3 binding. This result was confirmed by Pob3 co-immunoprecipitation of tagged Spt16-DeltaCTD polypeptide from trypsin-treated FACT, and by the purification of a complex of Pob3 and Mid domain from an extract of cells harboring a plasmid expressing the Mid-domain tagged with the flag epitope and the SV40 NLS (data not shown). These in vivo findings are also supported by the in vitro experiments described below. Pob3 interaction is thus provided mainly by the Spt16 Mid domain.
###end p 42
###begin title 43
Pob3 domains suggested by partial proteolysis
###end title 43
###begin p 44
###xml 92 93 92 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 178 182 178 182 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 195 196 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f3">3</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f3">3</xref>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c1">1</xref>
###xml 562 566 562 566 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 584 585 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f3">3</xref>
###xml 633 634 633 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1066 1067 1066 1067 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1072 1078 1072 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1072 1078 <span type="species:ncbi:562">E.coli</span>
In the context of FACT, Pob3 is more resistant than Spt16 to proteolytic treatments (Figure 2C, and data not shown). However, a higher concentration of trypsin cleaved the Spt16-flag*Pob3-(V5+His6) version of FACT to generate two major C-terminal Pob3 fragments, of apparent sizes 62 and 50 kDa including the tag (Figure 3). Glu-C gave similar Pob3 fragments (Figure 3, and data not shown). [Electrophoretic mobilities of the 551-residue Pob3 protein and tagged derivatives are lower than that predicted by molecular mass; (1)]. Probing the same blots with anti-flag antibody (Figure 3) showed that the appearance of the Pob3-(V5+His6) fragments coincided with extensive cleavage of Spt16, suggesting that protease-sensitive sites in Pob3 are shielded by Spt16 protein. Assignment of Pob3 cleavage sites is complicated by the uncertainty in molecular weight estimates due to the anomalous electrophoretic mobilities noted above, and the instability of Pob3 fragments produced by FACT cleavage. Nonetheless, some insight was provided by the expression of Pob3-(V5+His6) in E.coli cells, which yielded C-terminal fragments due to cleavages at residues 214 and 221 (data not shown). Based on all of these findings, our preliminary prediction is that Pob3 has 23 kDa NTDs and 40 kDa CTDs that are stabilized by association with the Mid domain of Spt16. The resistance of Pob3 to cleavage suggests that this boundary region may be sequestered in FACT.
###end p 44
###begin title 45
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
In vitro dissection of Spt16*Pob3 interactions
###end title 45
###begin p 46
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f4">4</xref>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f4">4</xref>
FACT subunit interactions were assessed directly using GST-pulldown assays with recombinant Spt16 and Pob3 polypeptides. Several purified recombinant Spt16 polypeptide fragments, each fused N-terminally to a cassette of thioredoxin, His6, and S-tag (THS; Figure 4A), were assayed for binding to GST-Pob3 fusions. Each recombinant THS-Spt16 peptide was mixed with equimolar amounts of GST-Pob3 or GST bound to glutathione-agarose beads, and bound material was assessed by western blotting for S-tagged Spt16 peptides. Results are summarized in Figure 4A.
###end p 46
###begin p 47
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f4">4</xref>
###xml 362 363 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f4">4</xref>
As expected, avid binding to GST-Pob3 was seen for THS-Spt16(436-1035) recombinant protein, containing the Mid and C-terminal domains (Figure 4B). Stronger binding to GST-Pob3 was repeatedly found for an approximately45 kDa S-tagged proteolytic fragment of THS-Spt16(436-1035), even though this fragment was not abundant in the input or unbound material (Figure 4B, arrowhead). The presence of the S-tag shows that this fragment contains Mid-domain sequences (436 to approximately700, taking into account the THS tag), indicating the expected strong Pob3 binding by the Mid domain.
###end p 47
###begin p 48
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f4">4</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f4">4</xref>
The Mid and C-terminal domains of Spt16 were tested separately for Pob3 binding. The CTD polypeptides THS-Spt16(710-1035) and THS-Spt16(771-1035) each failed to associate with GST-Pob3 (data not shown), as expected from the results of partial proteolysis (Figure 2F). The Mid-domain polypeptides THS-Spt16(436-786) and THS-Spt16 (436-821) associated non-specifically with the GST-bound agarose beads (data not shown), but higher-stringency washes indicated specific and strong binding to GST-Pob3 by the Mid domain THS-Spt16(436-786) (Figure 4C). THS-Spt16 (635-1035) and THS-Spt16(308-642), containing Mid-domain fragments, associated far less avidly with GST-Pob3 (Figure 4B), suggesting that the Mid domain needs to be intact for effective Pob3 binding.
###end p 48
###begin p 49
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f4">4</xref>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
The NTD polypeptide THS-Spt16(1-435) bound weakly but reproducibly to GST-Pob3 (Figure 4B), analogously to the binding of the Spt16 NTD to the rest of FACT after partial proteolysis (Figure 2E). Thus the NTD may also be involved in Pob3 binding.
###end p 49
###begin p 50
###xml 599 600 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f4">4</xref>
Experiments to determine the Spt16-interacting region(s) of Pob3 used GST fusions mimicking the domains suggested by partial proteolysis. GST-Pob3N, containing Pob3 residues 1-215, and GST-Pob3C, containing Pob3 residues 178-552, were incubated at equimolar amounts with purified recombinant THS-Spt16 peptides. The THS-Spt16(436-1035) Mid+CTD polypeptide bound specifically to both GST-Pob3N and GST-Pob3C polypeptides, and not to the GST-bound beads (data not shown), and at higher stringency the two Spt16 Mid-domain polypeptides interacted specifically with both GST-Pob3N and GST-Pob3C (Figure 4D). Pob3 may therefore have two binding surfaces for Cdc68.
###end p 50
###begin title 51
NTD point mutations destabilize the Spt16 polypeptide
###end title 51
###begin p 52
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c17">17</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c43">43</xref>
###xml 496 507 496 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-G132D</italic>
###xml 523 530 523 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc68-1</italic>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c24">24</xref>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
###xml 815 816 815 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 908 917 908 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-16a</italic>
###xml 945 952 945 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-8</italic>
###xml 968 976 968 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-24</italic>
###xml 990 998 990 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-12</italic>
###xml 1248 1250 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c43">43</xref>
###xml 1762 1763 1752 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f5">5</xref>
###xml 1863 1865 1849 1851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c20">20</xref>
###xml 1976 1977 1958 1959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f5">5</xref>
###xml 2051 2056 2033 2038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
###xml 2202 2211 2184 2193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-16a</italic>
###xml 2213 2220 2195 2202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-8</italic>
###xml 2222 2230 2204 2212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-24</italic>
###xml 2235 2243 2217 2225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-12</italic>
###xml 2265 2276 2247 2258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-G132D</italic>
###xml 2278 2280 2260 2262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c24">24</xref>
The finding that the Spt16 NTD is dispensable for essential functions appears inconsistent with the presence of point mutations in this domain that compromise essential functions. Several mutant versions of Spt16 with substitutions only in the NTD bring about temperature sensitivity for cell proliferation (4,17). For at least one Spt16 NTD mutation, causing a G132D substitution, temperature sensitivity is accompanied by destabilization of the mutant protein (43). Increased expression of the spt16-G132D mutant allele (cdc68-1), using a multicopy plasmid, alleviates much of this temperature sensitivity (24), consistent with temperature sensitivity due to an abnormally short Spt16 half-life. We therefore tested several other temperature-sensitive spt16 mutant alleles with point mutations affecting the NTD (4). Isogenic strains were created in which four mutant alleles encoding NTD point mutations, spt16-16a (R204W,A273V,C290V,D318N), spt16-8 (G369D,R373T), spt16-24 (T434I), and spt16-12 (A417T plus downstream substitutions), present on centromeric (low-copy) plasmids, supplied only the Spt16 protein. These mutant proteins, plus deleted proteins described here and analogously expressed, were evaluated for half-life as described in (43). Logarithmically growing cells were treated with the protein-synthesis inhibitor cycloheximide to stop the production of new polypeptides, and the relative abundance of pre-existing Spt16 protein was determined by western analysis. In each case the addition of cycloheximide immediately halted cell proliferation (data not shown). With the exception of the Spt16-Delta369 polypeptide, all mutant proteins were relatively stable at 23degreesC, as indicated by polypeptide abundance in the growing cells (Figure 5). In contrast, every tested protein with an NTD alteration, with the exceptions of Spt16-Delta922 (20) and Spt16-Delta(6-435), showed significant decreases in abundance during high-temperature incubation (Figure 5). The temperature sensitivities displayed by cells with these N-terminal spt16 mutations may therefore be related to the shorter half-lives of the mutant proteins at a restrictive temperature. Consistent with this idea, the spt16-16a, spt16-8, spt16-24 and spt16-12 mutant alleles, like spt16-G132D (24), allow high-temperature growth when present on multicopy plasmids (data not shown).
###end p 52
###begin p 53
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f5">5</xref>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
Spt16-312 and Spt16-319, two novel temperature-sensitive proteins with substitutions in the Mid and C-terminal domains (A.F. O'Donnell, G.C. Johnston and R.A. Singer, in preparation) had longer half-lives at the restrictive temperature (Figure 5), and increased expression from multicopy plasmids did not alleviate temperature sensitivity (data not shown). Thus spt16 temperature sensitivity is not invariably accompanied by Spt16 polypeptide instability.
###end p 53
###begin title 54
The Spt16 NTD influences essential FACT functions
###end title 54
###begin p 55
###xml 296 310 296 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 366 375 362 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-312</italic>
###xml 451 462 447 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-E857K</italic>
###xml 536 552 532 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;N,312</italic>
###xml 557 575 549 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;N,E857K</italic>
###xml 640 654 622 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 656 665 634 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-312</italic>
###xml 670 681 648 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-E857K</italic>
###xml 690 691 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f6">6</xref>
###xml 747 761 725 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 799 808 773 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-319</italic>
###xml 1124 1125 1080 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f6">6</xref>
###xml 1269 1270 1217 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f6">6</xref>
The NTD of Spt16, although dispensable under normal growth conditions, is conserved in sequence across the eukaryotic spectrum, suggesting an important function for this domain. Therefore, indications of an important function were sought through genetic means. Combining the deletion mutation of spt16-DeltaNTD with the downstream point mutations characterizing the spt16-312 allele mentioned above, or with the E857K substitution mutation encoded by spt16-E857K (A.F. O'Donnell, unpublished data), yielded plasmid-borne mutant alleles spt16-DeltaN,312 and spt16-DeltaN,E857K that are unable to support growth at 37degreesC, in contrast to spt16-DeltaNTD, spt16-312 and spt16-E857K (Figure 6A). It is even more striking to note that combining the spt16-DeltaNTD deletion with the point mutations of spt16-319 created a version of Spt16 unable to support growth even at 30degreesC (data not shown). Polypeptide degradation may not contribute to these effects; the Spt16-DeltaN,319, Spt16-DeltaN,312 and Spt16-DeltaN,E857K polypeptides are abundant and stable when expressed from a low-copy plasmid in wild-type cells (Figure 6B), and Spt16-DeltaN,312 and Spt16-DeltaN,E857K, as the sole Spt16 polypeptide in cells, are also stable at the restrictive temperature (Figure 6C). These findings suggest that the Spt16 NTD, although without essential function, can influence the essential functions(s) of downstream Spt16 domains.
###end p 55
###begin p 56
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pob3</italic>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c28">28</xref>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pob3</italic>
###xml 249 263 249 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 337 338 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f6">6</xref>
More insight was provided by the use of mutations altering the other FACT subunit, Pob3. Temperature-sensitive pob3 mutations affect cells in ways that implicate Pob3 in DNA replication (28). Combining temperature-sensitive pob3 mutant alleles with spt16-DeltaNTD gave double-mutant cells with enhanced temperature sensitivities (Figure 6D). These findings suggest that the NTD of Spt16 influences replication-related function(s) of Pob3, and may have a role in replication.
###end p 56
###begin title 57
A replication function for the Spt16 NTD
###end title 57
###begin p 58
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c28">28</xref>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c48">48</xref>
Involvement of the Spt16 NTD in replication was substantiated by investigations involving HU. This free-radical scavenger causes replication stress by inhibiting the enzyme ribonucleotide reductase and decreasing the synthesis of deoxyribonucleotides needed for DNA replication. Several FACT mutations cause sensitivity to HU (4,28). Cells lacking the Spt16 NTD also exhibit sensitivity to HU (Figure 7A). These cells also are sensitive to methylmethane sulfonate, another inducer of replication stress [data not shown; (48)]. Therefore the Spt16 NTD, although dispensable for normal DNA replication, becomes important during times of replication stress.
###end p 58
###begin p 59
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c49">49</xref>
###xml 599 600 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c50">50</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c52">52</xref>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c53">53</xref>
###xml 1181 1182 1181 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 1247 1261 1241 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 1266 1277 1256 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 1344 1345 1330 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 1743 1757 1723 1733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 1762 1773 1738 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 1802 1803 1774 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
Sensitivity to HU can indicate several deficiencies, including impaired checkpoint signaling during DNA replication. When replication-fork activity stalls, as in response to a shortage of deoxynucleotide substrates, the replication checkpoint is activated. This checkpoint signaling has several effects, including inhibition of mitosis, relief of transcriptional repression for genes encoding ribonucleotide reductase, and ultimately the restoration of replication-fork function [reviewed in (49)]. Malfunction of this checkpoint signaling causes sensitivity to chronic exposure to HU, as in Figure 7A. A more direct measure of checkpoint function is the degree of resistance to acute, short-term HU exposure, which indicates whether checkpoint-mediated activities can spare a cell from irreversible damage related to replication-fork collapse (50-52). Control cells lacking the checkpoint proteins, Mre11 or Xrs2 were subjected to an 8 h exposure to a high concentration (200 mM) of HU and then transferred to solid HU-free medium to assess colony formation. As expected (53), these mutant cells with impaired checkpoint signaling failed to survive the acute HU treatment (Figure 7B). In marked contrast, the same HU treatment (at 30degreesC) of spt16-DeltaNTD and spt16-Delta(6-435) mutant cells did not impair colony-forming ability (Figure 7B, and data not shown), and the treated cells were uniformly of the big-bud phenotype characteristic of checkpoint arrest (data not shown). This sensitivity to chronic HU treatment but normal resistance to acute HU treatment was seen in both the S288c and W303 genetic backgrounds. Similar assessment at 35degreesC, or with a 24 h HU exposure, also indicated that checkpoint signaling is intact in spt16-DeltaNTD and spt16-Delta(6-435) mutant cells (Figure 7B, and data not shown). Thus the absence of the Spt16 NTD does not prevent this critical aspect of checkpoint signaling.
###end p 59
###begin p 60
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c54">54</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 380 394 380 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 515 529 505 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
Checkpoint signaling was also assessed biochemically. Activation of checkpoint signaling leads to phosphorylation of the checkpoint protein Rad53, stimulation of the protein kinase activity of Rad53 for downstream signaling and decreasing Rad53 electrophoretic mobility (54). Figure 7C shows that Rad53 protein has shifted to a lower electrophoretic mobility upon HU treatment of spt16-DeltaNTD and wild-type cells at both 30 and 35degreesC, indicating that Rad53 is phosphorylated effectively upon HU treatment of spt16-DeltaNTD mutant cells.
###end p 60
###begin p 61
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c55">55</xref>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR3</italic>
###xml 277 291 277 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 331 332 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 625 639 621 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
One important consequence of replication-checkpoint signaling is an increase in ribonucleotide reductase expression (55). Direct assessment of endogenous mRNA levels for RNR1 and RNR3, which encode ribonucleotide reductase subunits, indicated that both genes were activated in spt16-DeltaNTD mutant cells upon HU treatment (Figure 7D). Therefore the existence of at least two responses to checkpoint signaling, ribonucleotide reductase activation and maintenance of replication-fork stability as indicated by resistance to acute HU treatment, as well as Rad53 phosphorylation, indicate that checkpoint signaling is active in spt16-DeltaNTD mutant cells.
###end p 61
###begin p 62
###xml 35 49 35 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 91 92 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 145 149 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 154 158 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR3</italic>
###xml 241 255 237 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 324 325 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 399 413 385 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 464 465 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 583 586 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR</italic>
###xml 609 623 585 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 917 931 889 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 982 986 950 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 990 994 958 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR3</italic>
###xml 1091 1093 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c50">50</xref>
###xml 1123 1127 1091 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 1131 1135 1099 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR3</italic>
###xml 1192 1206 1160 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 1228 1229 1192 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 1312 1314 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c56">56</xref>
###xml 1461 1463 1425 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c57">57</xref>
###xml 1468 1477 1432 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sml1&#916;</italic>
###xml 1573 1575 1533 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c58">58</xref>
###xml 1587 1596 1547 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sml1&#916;</italic>
###xml 1636 1650 1592 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 1665 1666 1617 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
Despite this checkpoint signaling, spt16-DeltaNTD mutant cells are sensitive to HU (Figure 7A). We noted that during HU treatment high levels of RNR1 and RNR3 mRNAs were maintained in wild-type cells, whereas mRNA abundances had declined in spt16-DeltaNTD mutant cells by the 4 h timepoint, especially at 35degreesC (Figure 7D). This decline paralleled the decline in Rad53 phosphorylation seen for spt16-DeltaNTD mutant cells at this 35degreesC timepoint (Figure 7C). The Spt16 NTD may therefore facilitate sustained checkpoint signaling. The decline in checkpoint signaling and in RNR gene transcription in spt16-DeltaNTD mutant cells upon extended HU exposure raised the possibility that ribonucleotide reductase activity in these mutant cells might become insufficient for the restart of stalled replication forks. However, two lines of evidence suggest that ribonucleotide reductase activity is not deficient in spt16-DeltaNTD mutant cells. Ectopic expression of plasmid-borne RNR1 or RNR3 from the constitutive GAP promoter can alleviate HU sensitivity for checkpoint-deficient cells (50). However, overexpression of RNR1 or RNR3 from these plasmids did not alter the HU sensitivity of spt16-DeltaNTD mutant cells (Figure 7E). We also eliminated the Sml1 protein, an inhibitor of ribonucleotide reductase (56). Checkpoint signaling causes the phosphorylation and degradation of Sml1, releasing preexisting ribonucleotide reductase enzyme from inhibition (57). A sml1Delta mutation makes cells resistant to HU and allows growth in the absence of checkpoint signaling (58). However, sml1Delta did not abrogate the HU sensitivity of spt16-DeltaNTD cells (Figure 7F). These experiments suggest that the Spt16 NTD may mediate an activity downstream of checkpoint signaling itself, perhaps related to the resumption of replication by stalled replication forks.
###end p 62
###begin title 63
###xml 57 62 <span type="species:ncbi:4932">yeast</span>
Genetic indications of several replication functions for yeast FACT
###end title 63
###begin p 64
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c28">28</xref>
###xml 273 291 273 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;N,E857K</italic>
###xml 390 404 386 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 408 419 400 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-E857K</italic>
###xml 439 440 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 463 482 455 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD pob3</italic>
###xml 552 553 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
###xml 40 45 <span type="species:ncbi:4932">yeast</span>
Sensitivity to HU has been reported for yeast FACT mutants that have an intact Spt16 NTD (4,28). To determine whether these HU sensitivities are related to the actions of the NTD, genetic interactions between FACT mutations were assessed. These experiments showed that the spt16-DeltaN,E857K mutant allele described above causes a degree of HU sensitivity greater than that shown by either spt16-DeltaNTD or spt16-E857K themselves (Figure 7G). Similarly, several spt16-DeltaNTD pob3 double-mutant derivatives exhibited synthetic HU sensitivity (Figure 7H). These findings suggest that FACT is involved in replication-fork activities in several ways, both dependent on and independent of the Spt16 NTD.
###end p 64
###begin title 65
DISCUSSION
###end title 65
###begin p 66
###xml 124 129 <span type="species:ncbi:4932">yeast</span>
We report here an initial analysis, through genetic and biochemical analysis, of the domain organization of the subunits of yeast FACT. The domain interactions responsible for FACT integrity as determined here, and the functional aspects of the NTD of the Spt16 subunit, suggest that FACT functions may also be partially compartmentalized to domains.
###end p 66
###begin title 67
Domain organization of the FACT subunits
###end title 67
###begin p 68
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 774 775 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c40">40</xref>
###xml 369 374 <span type="species:ncbi:4932">yeast</span>
###xml 762 767 <span type="species:ncbi:4932">yeast</span>
The Spt16 protein may be folded into three major domains, as indicated by partial-proteolysis experiments, N-terminal sequence data and genetic findings (Figure 2D). The domain boundaries map to localized regions of low sequence conservation among Spt16 homologs from diverse species. Our findings suggest that Pob3 may be folded into two domains, separated by a short yeast-specific insert within the conserved Pob3/SSRP1 family. The SSRP1 members of the Pob3/SSRP1 protein family also have an HMG domain appended C-terminally. This HMG sequence is likely to be another independently folded portion of the polypeptide, given that this type of HMG domain is an independently folded entity in many contexts. The small HMG protein Nhp6 may provide this domain for yeast FACT (4,40).
###end p 68
###begin title 69
FACT integrity
###end title 69
###begin p 70
###xml 67 74 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 109 117 109 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 225 233 225 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c59">59</xref>
The Spt16 Mid domain is intact in Spt16 derivatives that bind Pob3 in vivo, and also binds Pob3 polypeptides in vitro. FACT is therefore stabilized through Pob3 interactions with the Spt16 Mid domain. Conversely, Spt16 binds in vitro to two different recombinant Pob3 polypeptides encompassing the NTDs and CTDs. Although these two Pob3 fragments have residues 178-215 in common, much of this 'overlap' sequence is absent from metazoan Pob3 homologs and most likely comprises a domain boundary. This 38-residue region is therefore unlikely to be responsible for the similar interactions of these two Pob3 fragments with Spt16. An internal duplication in Pob3/SSRP1 proteins has been reported that may produce similar polypeptide folds (59). This duplication spans Pob3 residues 4-104 and 374-475, placing one duplicated subdomain in each of the Pob3 domains that binds Spt16. This tandem duplication may provide binding surfaces for Spt16, one within each of the suggested Pob3 domains.
###end p 70
###begin p 71
###xml 10 18 10 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 75 85 75 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c10">10</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c36">36</xref>
###xml 123 133 123 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 264 274 240 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 307 315 283 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 510 520 486 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 549 557 525 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 566 567 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f4">4</xref>
###xml 675 685 651 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 75 85 <span type="species:ncbi:7227">Drosophila</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 123 133 <span type="species:ncbi:7227">Drosophila</span>
###xml 158 163 <span type="species:ncbi:4932">yeast</span>
###xml 190 195 <span type="species:ncbi:9606">human</span>
###xml 264 274 <span type="species:ncbi:7227">Drosophila</span>
###xml 389 394 <span type="species:ncbi:4932">yeast</span>
###xml 466 471 <span type="species:ncbi:4932">yeast</span>
###xml 510 520 <span type="species:ncbi:7227">Drosophila</span>
###xml 665 670 <span type="species:ncbi:9606">human</span>
###xml 675 685 <span type="species:ncbi:7227">Drosophila</span>
###xml 807 812 <span type="species:ncbi:4932">yeast</span>
Analogous in vitro interaction studies have been carried out for human and Drosophila FACT (10,36). Fragments of human and Drosophila Spt16, corresponding to yeast residues 337-657 (for the human fragment), and approximately460-1035 and approximately630-1035 (for Drosophila fragments), were sufficient for in vitro SSRP1 binding. Thus in both metazoan cases, regions corresponding to the yeast Mid domain were involved. Note, however, that the 645-1035 fragment of yeast Spt16, analogous to the SSRP1-binding Drosophila fragment, did not bind Pob3 in vitro (Figure 4B), perhaps as a consequence of improper folding. The expected lack of interaction was also seen; human and Drosophila Spt16 polypeptide fragments that did not bind SSRP1 corresponding to N-terminal Spt16 sequences that are dispensable for yeast FACT integrity.
###end p 71
###begin p 72
###xml 133 141 133 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c36">36</xref>
###xml 268 278 268 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c10">10</xref>
###xml 56 61 <span type="species:ncbi:4932">yeast</span>
###xml 99 104 <span type="species:ncbi:9606">Human</span>
###xml 268 278 <span type="species:ncbi:7227">Drosophila</span>
Correspondence between interactions within metazoan and yeast FACT is less evident for SSRP1/Pob3. Human SSRP1 was found to interact in vitro with hSpt16 through N-terminal sequences, whereas the downstream hSSRP1 fragments that were tested did not interact (36). For Drosophila FACT, the opposite pattern was seen, with C-terminal dSSRP1 sequences mediating dSpt16 interaction and N-terminal sequences remaining inert (10). Resolution of these differences awaits further study.
###end p 72
###begin title 73
The Spt16 CTD
###end title 73
###begin p 74
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 176 190 176 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;CTD</italic>
###xml 323 330 319 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 592 594 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c11">11</xref>
###xml 456 461 <span type="species:ncbi:9606">human</span>
The CTD of Spt16 does not make stable associations with Pob3 or upstream Spt16 domains (Figure 2F), and therefore may be tethered loosely to the rest of FACT. We found that an spt16-DeltaCTD mutant allele cannot keep cells alive, but attempts to understand the biological effects of the CTD have so far been stymied by the in vivo instability of Spt16-DeltaCTD polypeptide (J. R. Stevens, G.C.J. and R.A.S., unpublished observations). However, recombinant human Spt16 lacking C-terminal residues corresponding to most of the CTD also lacks the histone-binding activity of full-length hSpt16 (11), suggesting that the Spt16 CTD may function as a mobile histone-binding domain.
###end p 74
###begin title 75
NTD fragments and FACT function
###end title 75
###begin p 76
###xml 22 33 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 45 59 41 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
The phenotypes of the spt16-Delta(5-435) and spt16-DeltaNTD alleles, encoding Spt16 polypeptides lacking the NTD, indicate that the NTD is not essential for growth at 37degreesC or for chromatin repression of transcription, and therefore these properties depend on Spt16 Mid and CTD domains. However, Spt16 polypeptides in which only a fragment of the NTD is appended to Mid+CTD, such as Spt16-Delta922 and Spt16-Delta369, are compromised for these functions. These observations suggest that the NTD fragments in these polypeptides may be misfolded to an extent that they interfere with proper Mid+CTD function or with Pob3 function.
###end p 76
###begin p 77
###xml 228 230 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c59">59</xref>
###xml 231 233 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c60">60</xref>
###xml 256 258 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c61">61</xref>
###xml 388 390 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c62">62</xref>
###xml 666 667 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
Structure predictions support the notion that the NTD fragments in the Spt16-Delta922 and Spt16-Delta369 polypeptides may indeed be misfolded. The Spt16 NTD resembles members of the 'pita-fold' family of aminopeptidase enzymes (59,60), with a type-I fold (61) predicted for an aminopeptidase-like NTD subregion. Eukaryotic aminopeptidases have another domain, of heterogeneous structure (62). This added NTD of eukaryotic aminopeptidase enzymes is mimicked, in size and position, by a potential subdomain of the Spt16 NTD, so that the entire Spt16 NTD resembles a type-Ib enzyme structure. NTD subdomains are in fact suggested by partial-proteolysis results (Figure 2A). In any case, the Spt16 NTD fragments studied here, in the Spt16-Delta922 and Spt16-Delta369 polypeptides, each lack approximately half of the putative 'pita-fold' subdomain.
###end p 77
###begin title 78
Spt16 NTD function
###end title 78
###begin p 79
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c10">10</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c36">36</xref>
###xml 480 494 480 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 666 669 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR</italic>
###xml 684 685 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f7">7</xref>
The experiments reported here, and related ones concerning metazoan FACT (10,36), suggest that the NTD of the FACT subunit Spt16 is not critical for FACT integrity. This domain is almost certainly, therefore, involved in interactions with other proteins. However, these interactions are not important for global transcription if the rest of FACT is intact. On the other hand, NTD interactions are important under conditions of replication stress, as evidenced by the phenotype of spt16-DeltaNTD mutant cells. Even during replication stress these interactions may not affect transcription, because the Spt16 NTD is not necessary for transcriptional activation of the RNR genes (Figure 7D). The Spt16 NTD may therefore be important for the restart of stalled replication forks that accumulate upon replication stress.
###end p 79
###begin p 80
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c63">63</xref>
###xml 482 490 482 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 533 535 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c36">36</xref>
###xml 589 591 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c35">35</xref>
###xml 592 594 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c36">36</xref>
###xml 679 681 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c64">64</xref>
###xml 740 742 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c65">65</xref>
###xml 796 798 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c37">37</xref>
###xml 425 430 <span type="species:ncbi:9606">human</span>
###xml 789 794 <span type="species:ncbi:4932">yeast</span>
The postulated NTD interactions during replication stress are not obvious. The NTD interacts with the Sas3 component of the NuA3 histone acetyltransferase complex (63). Although this interaction has certain transcription-related effects, an appreciation of the consequences of this interaction awaits further investigation. A more relevant interaction for replication stress may involve the protein kinase CK2. A fragment of human Spt16 encompassing a majority of the NTD interacts in vitro with the alpha' catalytic subunit of CK2 (36) in a complex that phosphorylates and activates p53 (35,36). Activation of p53 takes place upon replication stress brought on by HU treatment (64), and p53 becomes localized to stalled replication forks (65). An analogous CK2*FACT association exists in yeast (37), but its significance is currently unclear.
###end p 80
###begin title 81
Figures and Tables
###end title 81
###begin p 82
###xml 22 23 22 23 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 138 149 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;</italic>
###xml 256 257 252 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 415 416 411 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 451 452 447 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
 Spt16 polypeptides. (A) Structures and biological activities of polypeptides deleted for N-terminal sequences. The in-frame deletions in spt16-Delta(6-435) are separated by Spt16 sequence (with one substitution due to codon joining). NA, not assessable. (B) Spt16 polypeptides lacking N-terminal sequences interact effectively with the FACT subunit Pob3. Anti-V5 antibody was used to immunoprecipitate Pob3-(V5+His6) from cells harboring Pob3-(V5+His6), wild-type full-length Spt16, and either Spt16-Delta(6-435) or Spt16-DeltaNTD. Spt16 polypeptides and Pob3 were identified in the immunoprecipitate (IP) and supernate (S) fractions by western blotting. Different exposures of the Spt16 blots (15 s for supernates versus 60 s for IPs) are shown to emphasize relative abundances.
###end p 82
###begin p 83
###xml 77 78 77 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c1">1</xref>
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 375 376 375 376 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 410 414 410 414 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 431 432 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 509 513 509 513 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 537 541 537 541 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 581 582 581 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 742 743 742 743 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 911 912 911 912 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1132 1133 1132 1133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 1188 1192 1188 1192 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 1252 1256 1252 1256 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
 Domain organization of the Spt16 subunit through FACT partial proteolysis. (A) Purified FACT (1) composed of epitope-tagged HA-Spt16 and Pob3-(V5+His6) was treated with trypsin for increasing times, resolved electrophoretically through a 10% polyacrylamide gel, and analyzed by western blotting using anti-HA antibody. N-terminally HA-tagged Spt16 fragments are indicated. (B) Purified FACT composed of Spt16-flag and Pob3-(V5+His6) was treated with trypsin or chymotrypsin and similarly analyzed using anti-flag antibody. C-terminally flag-tagged Spt16 fragments are indicated. (C) Purified FACT was trypsin-digested, resolved electrophoretically and silver-stained. Band identification was confirmed by western blotting (data not shown). (D) Spt16 domain organization, with likely subdomain boundaries indicated by arrows. Products of trypsin (T), Glu-C (E), and chymotrypsin (C) proteolysis are indicated. (E) Material from trypsin-digested FACT containing HA-Spt16 was resolved by exclusion chromatography, and the resulting fractions were resolved electrophoretically and analyzed by western blotting using anti-HA antibody. (F) Material from trypsin-digested FACT containing Spt16-flag was analyzed as in (E) using antibody against V5 (top) and flag (bottom). In this experiment, trypsin cleaved off the Spt16 NTD from all detectable FACT.
###end p 83
###begin p 84
###xml 107 111 107 111 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 128 129 128 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f2">2</xref>
###xml 346 350 346 350 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
###xml 376 380 376 380 <sc xmlns:xlink="http://www.w3.org/1999/xlink">flag</sc>
 Domain organization of the Pob3 subunit through FACT partial proteolysis. Purified FACT composed of Spt16-flag and Pob3-(V5+His6) was treated with Glu-C or trypsin, and samples removed at increasing times were analyzed as in Figure 2, using anti-V5 antibody to detect Pob3 C-terminal polypeptides. Membranes were stripped and reprobed with anti-flag antibody to assess Spt16-flag cleavage.
###end p 84
###begin p 85
###xml 25 33 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 36 37 36 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 299 300 299 300 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 515 516 515 516 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 735 736 735 736 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
 Spt16-Pob3 interactions in vitro. (A) Schematic of recombinant Spt16 (side) and GST-Pob3 (top) polypeptides used, and the interactions indicated by western analysis of Spt16 polypeptides. The THS at the N terminus of each Spt16 polypeptide is represented by the double circle. ND, not determined. (B) GST-Pob3 pulldowns of S-tagged Spt16 polypeptides. None of the Spt16 polypeptides interacted with GST-bound beads, and the THS moiety itself did not interact with beads carrying GST or GST-Pob3 (data not shown). (C) GST pulldowns of the Spt16(436-786) Mid domain, using high-stringency buffer B. Lanes 1 and 3, S-tagged Spt16(436-786); lanes 2 and 4, the THS moiety; lanes 5-8, input for the experiments of lanes 1-4, respectively. (D) Interactions (buffer B) of the Mid-domains Spt16(436-786) and Spt16(463-821) with GST-Pob3 polypeptides bearing N- or C-terminal residues 1-215 and 178-552, respectively.
###end p 85
###begin p 86
###xml 53 63 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16&#916;</italic>
###xml 104 109 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
###xml 170 171 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c4">4</xref>
###xml 418 420 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c66">66</xref>
 Spt16 polypeptide stabilities. Extracts of isogenic spt16Delta derivatives maintained by plasmid-borne spt16 mutant alleles, including several with NTD point mutations (4), were made from cells growing at 23degreesC (-) or incubated at 39degreesC for 1 h with the protein-synthesis inhibitor cycloheximide (+), resolved electrophoretically, and assessed by western analysis for Spt16 polypeptide. India ink staining (66) prior to anti-Spt16 antibody binding (data not shown) and the 40 kDa non-specific band verified equal loading. The resected polypeptides Spt16-Delta922, Spt16-Delta(6-435), and Spt16-Delta369 have higher mobilities than full-length Spt16.
###end p 86
###begin p 87
###xml 5 19 5 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 65 66 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 107 117 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16&#916;</italic>
###xml 181 186 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
###xml 277 278 269 270 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 347 352 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
###xml 480 481 466 467 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 492 502 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16&#916;</italic>
###xml 534 539 516 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
###xml 614 615 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f5">5</xref>
###xml 671 672 653 654 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 703 712 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pob3&#916;</italic>
###xml 720 725 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPT16</italic>
###xml 731 751 709 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16&#916; pob3&#916;</italic>
###xml 774 788 744 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 798 812 764 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 852 856 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pob3</italic>
###xml 867 871 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POB3</italic>
 The spt16-DeltaNTD mutation affects essential FACT activities. (A) Five-fold serial dilutions of isogenic spt16Delta derivatives maintained by the indicated low-copy plasmid-borne spt16 mutant alleles were spotted onto rich medium and incubated at the indicated temperature. (B) Extracts of 30degreesC wild-type cells harboring the same low-copy spt16 mutant plasmids were assessed by western analysis for Spt16 polypeptide. The asterisk indicates the non-specific 40 kDa band. (C) Isogenic spt16Delta derivatives with plasmid-borne spt16 mutant alleles were assessed for Spt16 polypeptide stability as in Figure 5. The asterisk indicates the non-specific 40 kDa band. (D) Serial dilutions of isogenic pob3Delta cells (SPT16) and spt16Delta pob3Delta cells with a low-copy spt16-DeltaNTD plasmid (spt16-DeltaNTD), maintained by the indicated low-copy pob3 mutant or POB3 plasmids, were spotted on rich medium and incubated at 35degreesC.
###end p 87
###begin p 88
###xml 41 42 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 83 93 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16&#916;</italic>
###xml 136 150 132 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 154 159 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPT16</italic>
###xml 279 280 271 272 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 520 530 512 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mre11&#916;</italic>
###xml 535 544 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">xrs2&#916;</italic>
###xml 552 554 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c67">67</xref>
###xml 611 620 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">leu1&#916;</italic>
###xml 671 672 651 652 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 908 909 888 889 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 911 915 891 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 920 924 900 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR3</italic>
###xml 1121 1125 1101 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TUB2</italic>
###xml 1260 1261 1240 1241 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1333 1337 1313 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR1</italic>
###xml 1342 1346 1322 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNR3</italic>
###xml 1518 1519 1498 1499 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 1536 1545 1516 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sml1&#916;</italic>
###xml 1556 1558 1532 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh922c67">67</xref>
###xml 1597 1602 1573 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPT16</italic>
###xml 1606 1620 1582 1592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16-&#916;NTD</italic>
###xml 1746 1755 1712 1717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sml1&#916;</italic>
###xml 1780 1781 1742 1743 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 1822 1832 1784 1790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16&#916;</italic>
###xml 1882 1887 1840 1845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spt16</italic>
###xml 1980 1981 1932 1933 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 2043 2044 1995 1996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh922f6">6</xref>
 The Spt16 NTD mediates HU sensitivity. (A) Five-fold serial dilutions of isogenic spt16Delta derivatives maintained by a plasmid-borne spt16-DeltaNTD or SPT16 gene were spotted onto rich medium and incubated at the indicated temperature in the presence or absence of 50 mM HU. (B) Growing cells were transferred to rich medium with (+) or without (-) 200 mM HU, incubated for 8 h, and then serially diluted, transferred to HU-free solid medium, and incubated at the indicated temperature for colony formation. Isogenic mre11Delta and xrs2Delta cells (67) were positive controls for sensitivity, while isogenic leu1Delta and wild-type (WT) cells were negative controls. (C) Rad53 protein was detected by western analysis (using antibody from Santa Cruz Biotechnology) in extracts of growing cells incubated for the indicated times in rich medium containing 200 mM HU. Rad53P indicates phosphorylated Rad53. (D) RNR1 and RNR3 RNAs in extracts of growing cells incubated for the indicated times in rich medium containing 200 mM HU were detected by northern analysis, and quantified (bolded values in each lane) relative to TUB2 RNA values by densitometric analysis using multiple exposures and ImageJ software (US National Institutes of Health; available at ). (E) Serial dilutions of stationary-phase cultures of cells harbouring the RNR1 and RNR3 expression plasmids pBAD070 and pBAD079, or the control plasmid pBAD054, were spotted on rich medium with or without 50 mM HU and incubated at the indicated temperature. (F) Cells with the sml1Delta deletion (67) and isogenic derivatives with tagged SPT16 or spt16-DeltaNTD at the chromosomal locus were spotted on rich medium with or without 50 mM HU and incubated at 30degreesC. Two segregants of sml1Delta derivatives are shown. (G) Five-fold serial dilutions of isogenic spt16Delta derivatives carrying the indicated plasmid-borne spt16 allele were spotted onto rich medium with or without 50 mM HU and incubated at 30degreesC. (H) Serial dilutions of cultures of the strains shown in Figure 6D were spotted on rich medium containing 100 mM HU and incubated at 30degreesC.
###end p 88
###begin title 89
ACKNOWLEDGEMENTS
###end title 89
###begin p 90
We thank Steve Elledge, Tim Formosa, LeAnn Howe and Jerry Workman for plasmids, Jeff Coles for preliminary experiments, David Carruthers and Kendra Gillis for technical assistance, and Chris Barnes for helpful discussions. This work was supported by a grant from the Canadian Institutes of Health Research. A.F.O. was supported by the Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes of Health Research, the Killam Foundation and the Nova Scotia Health Research Foundation. J.K. was supported by the Canadian Institutes of Health Research; L.V.M. was supported by grants from the Dalhousie Cancer Biology Research Group.
###end p 90
###begin title 91
REFERENCES
###end title 91

